LLY doesn’t (i.e. didn’t) have an infectious disease focus. The company website lists five therapeutic areas for the pipeline: cancer, cardiometabolic, immunology, neurodegneration, and pain.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”